参蛤河车胶囊联合布地奈德福莫特罗吸入剂对慢性阻塞性肺疾病急性加重期患者心肺功能、凝血功能及炎症状态的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563

基金项目:


Effect of Shenha Heche Capsules Combined with Budesonide Formoterol Inhalation on Cardiopulmonary Function, Coagulation Function and Inflammatory State in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察参蛤河车胶囊联合布地奈德福莫特罗吸入剂对慢性阻塞性肺疾病急性加重期(AECOPD) 患者心肺功能、凝血功能及炎症状态的影响。方法:选取108 例AECOPD 患者作为研究对象,按照不同治疗方法分为对照组和治疗组各54 例。2 组均给予常规对症治疗,对照组加用布地奈德福莫特罗吸入剂治疗,治疗组在对照组的基础上联合参蛤河车胶囊治疗。比较2 组临床疗效及治疗前后的心肺功能指标[左室射血分数(LVEF)、第1 秒用力呼气容积(FEV1)、FEV1/用力肺活量(FVC) ]、凝血功能指标[凝血活酶时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(Fib)]、血清炎症因子[白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)、C-反应蛋白(CRP)]水平。结果:治疗组总有效率为94.44%,对照组为77.78%,2 组比较,差异有统计学意义(P<0.05)。治疗前,2 组LVEF、FEV1、FEV1/FVC 水平比较,差异无统计学意义(P>0.05)。治疗后,2 组LVEF、FEV1、FEV1/FVC 水平均较治疗前升高(P<0.05),且治疗组各项指标均高于对照组(P<0.05)。治疗前,2 组PT、APTT、Fib、TT 水平比较,差异无统计学意义(P>0.05)。治疗后,2 组PT、APTT、Fib 水平均较治疗前改善(P<0.05),且治疗组PT、APTT、Fib 水平改善较对照组更显著(P<0.05);2 组TT 水平治疗前后变化无明显差异(P>0.05)。治疗前,2 组IL-8、TNF-α、CRP 水平比较,差异无统计学意义(P>0.05);治疗后,2 组血清IL-8、TNF-α、CRP 水平均较治疗前降低(P<0.05),且治疗组IL-8、TNF-α、CRP 水平均低于对照组(P<0.05)。结论:参蛤河车胶囊联合布地奈德福莫特罗吸入剂治疗AECOPD 疗效显著,可明显缓解患者的临床症状,有效改善心肺功能及凝血功能,减轻机体炎症反应。

    Abstract:

    Abstract:Objective:To observe the effect of Shenha Heche capsules combined with budesonide formoterol inhalation on cardiopulmonary function, coagulation function and inflammatory state in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD). Methods:A total of 108 patients with AECOPD were selected and divided into the control group and the treatment group according to different treatment methods,with 54 cases in each group. Both groups were given routine symptomatic treatment. The control group was additionally treated with budesonide formoterol inhalation, and the treatment group was additionally treated with Shenha Heche capsules based on the treatment of the control group. Before and after treatment, the clinical effects, cardiopulmonary function indexes[left ventricular ejection fraction(LVEF), forced expiratory volume in one second(FEV1) and FEV1/forced vital capacity(FVC)],coagulation function indexes [prothrombin time(PT), activated partial thromboplastin time(APTT), thrombin time(TT) and fibrinogen(Fib)], and serum inflammatory factors [levels of interleukin- 8(IL- 8), tumor necrosis factor- α(TNF- α), and C- reactive protein(CRP)] were compared between the two groups. Results: The total effective rate was 94.44% in the treatment group and 77.78% in the control group,the difference being significant(P<0.05). Before treatment,there was no significant difference being found in levels of LVEF,FEV1 and FEV1/FVC between the two groups(P>0.05). After treatment,the levels of LVEF,FEV1 and FEV1/FVC in the two groups were increased when compared with those before treatment(P<0.05), and the above indexes in the treatment group were higher than those in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of levels of PT,APTT,Fib and TT between the two groups(P>0.05). After treatment,the levels of PT,APTT and Fib in the two groups were improved when compared with those before treatment(P<0.05),and the improvement of the above three levels in the treatment group was more significant than that in the control group(P<0.05); before and after treatment,there was no significant difference being found in the comparison of TT levels between the two groups(P>0.05). Before treatment, there was no significant difference being found in the comparison of levels of IL- 8, TNF- α and CRP between the two groups(P>0.05); after treatment, the above three levels in the two groups were decreased when compared with those before treatment(P<0.05),and the above three levels in the treatment group were lower than those in the control group(P<0.05). Conclusion: The therapy of Shenha Heche capsules combined with budesonide formoterol inhalation has a remarkable curative effect on AECOPD, which can significantly alleviate the clinical symptoms of patients, effectively improve the cardiopulmonary function and coagulation function, and reduce the inflammatory responses of the body.

    参考文献
    相似文献
    引证文献
引用本文

平小锋.参蛤河车胶囊联合布地奈德福莫特罗吸入剂对慢性阻塞性肺疾病急性加重期患者心肺功能、凝血功能及炎症状态的影响[J].新中医,2022,54(10):100-104

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-05-24
  • 出版日期:
文章二维码